Back to results
US 7,803,768 B2Granted
Method for treatment of hyperglycemia in a subject in need thereof
AssigneesKyoto University, Daiichi Sankyo Company, Limited
InventorsKenji Kangawa, Takashi Akamizu, Taiga Irako, Shuichi Koda, Naomi Wakabayashi
Life of this patent
Estimating the term…
Abstract
A pharmaceutical for promoting neogenesis or regeneration of pancreatic β cells which produces and secretes insulin and for promoting insulin production in β cells, comprising ghrelin or a derivative thereof as an effective component.
Claims11
A method for suppression or treatment of hyperglycemia, which comprises administering an effective amount of a peptide compound or a pharmaceutically acceptable salt thereof, to a patient in need thereof,
- wherein the peptide compound is growth hormone-releasing peptide-2 (GHRP-2) or a peptide having an amino acid sequence of any one of SEQ ID NOs:
- 1 to 21 wherein the 3rd amino acid residue from an amino terminus is a modified amino acid residue wherein a side chain of the amino acid residue is acylated by a fatty acid.
Dependencies are inferred from the claim text.